Lv61
1900 积分 2024-02-08 加入
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
10天前
已完结
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
10天前
已完结
Safety and efficacy of FLAG-Ida-based therapy combined with venetoclax for the treatment for newly diagnosed and relapsed/refractory patients with AML – A systematic review
10天前
已完结
Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML
18天前
已完结
SOHO State of the Art Updates and Next Questions Acute Myeloid Leukemia: Current Status and Next Questions
18天前
已完结
How I use Maintenance Therapy in Acute Myeloid Leukemia
18天前
已完结
How I Treat: Differentiation Therapy in Acute Myeloid Leukemia
18天前
已完结
How I Treat patients with AML using azacitidine and venetoclax
18天前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
1个月前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
1个月前
已完结
皖公网安备34019202002308
